Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00255580 · ClinicalTrials.gov registry record · Phase 1
Medicinal Cannabis for Painful HIV Neuropathy
A Phase 1 study, sponsored by Center for Medicinal Cannabis Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT00255580 is a Phase 1 study that has completed, run by Center for Medicinal Cannabis Research. The registered enrollment target is 28 participants.
The verdict
NCT00255580, a Phase 1 study, has completed, sponsored by Center for Medicinal Cannabis Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if medicinal cannabis (marijuana) is safe and effective for treating pain in individuals with HIV-associated distal, sensory-predominant polyneuropathy (DSPN).
Interventions
- DRUG Smoked cannabis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2001-09 |
| Est. Completion | 2006-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00255580
The ClinicalTrials.gov registry entry for NCT00255580 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for Medicinal Cannabis Research, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Smoked cannabis is the first listed.
NCT00255580 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00255580 about?
NCT00255580 is a clinical study titled "Medicinal Cannabis for Painful HIV Neuropathy". The purpose of this study is to determine if medicinal cannabis (marijuana) is safe and effective for treating pain in individuals with HIV-associated distal, sensory-predominant polyneuropathy (DSPN).
What is the current status of trial NCT00255580?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2001-09. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00255580?
The interventions under investigation include: Smoked cannabis (DRUG).
Who is sponsoring clinical trial NCT00255580?
This trial is sponsored by Center for Medicinal Cannabis Research, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.